Search research articles
Contact Us
Filters
Showing results (131-140 of 224) with videos related to
Page
of 23
Sort By:
Biorxiv : the Preprint Server for Biology
|
January 30, 2023
Impact of rare structural variant events in newly diagnosed multiple myeloma
Monika Chojnacka, Benjamin Diamond, Bachisio Ziccheddu, et al.
Open Heart
|
June 22, 2023
Drugless and radiographer led: the start of a new era for CT coronary angiography
Gareth Morgan-Hughes, Rebecca McNally, Christopher Gibbs Gibbs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 6, 2016
Impact of Genes Highly Correlated with MMSET Myeloma on the Survival of Non-MMSET Myeloma Patients
S Peter Wu, Ruth M Pfeiffer, Inhye E Ahn, et al.
Leukemia & Lymphoma
|
December 5, 2008
Outcome of high-dose cytarabine-based induction therapy followed by hematopoietic stem cell transplantation in acute myeloid leukemia: influence of karyotype
Bhawna Sirohi, Ray Powles, Seema Singhal, et al.
Ecancermedicalscience
|
February 14, 2018
Healthy living and cancer: evidence from UK Biobank
Peter C Elwood, Alex Whitmarsh, John Gallacher, et al.
British Journal of Haematology
|
June 22, 2011
Tyrosine kinase inhibitor insensitivity of non-cycling CD34+ human acute myeloid leukaemia cells with FMS-like tyrosine kinase 3 mutations
Caroline L Alvares, Tino Schenk, Sanna Hulkki, et al.
Haematologica
|
October 26, 2010
Efficacy and outcome of autologous transplantation in rare myelomas
Curly Morris, Mary Drake, Jane Apperley, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 16, 2011
Adjusting for patient crossover in clinical trials using external data: a case study of lenalidomide for advanced multiple myeloma
K Jack Ishak, J Jaime Caro, Mark T Drayson, et al.
Haematologica
|
December 10, 2020
Autologous stem cell transplantation is safe and effective for fit older myeloma patients: exploratory results from the Myeloma XI trial
Charlotte Pawlyn, David Cairns, Tom Menzies, et al.
British Journal of Haematology
|
June 12, 2020
Early relapse after high-dose melphalan autologous stem cell transplant predicts inferior survival and is associated with high disease burden and genetically high-risk disease in multiple myeloma
Ceri Bygrave, Charlotte Pawlyn, Faith Davies, et al.
Page
of 23
Search research articles
Search
Showing results (131-140 of 224) with videos related to
Sort By:
Page
of 23
Biorxiv : the Preprint Server for Biology
|
January 30, 2023
Impact of rare structural variant events in newly diagnosed multiple myeloma
Monika Chojnacka, Benjamin Diamond, Bachisio Ziccheddu, et al.
Open Heart
|
June 22, 2023
Drugless and radiographer led: the start of a new era for CT coronary angiography
Gareth Morgan-Hughes, Rebecca McNally, Christopher Gibbs Gibbs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 6, 2016
Impact of Genes Highly Correlated with MMSET Myeloma on the Survival of Non-MMSET Myeloma Patients
S Peter Wu, Ruth M Pfeiffer, Inhye E Ahn, et al.
Leukemia & Lymphoma
|
December 5, 2008
Outcome of high-dose cytarabine-based induction therapy followed by hematopoietic stem cell transplantation in acute myeloid leukemia: influence of karyotype
Bhawna Sirohi, Ray Powles, Seema Singhal, et al.
Ecancermedicalscience
|
February 14, 2018
Healthy living and cancer: evidence from UK Biobank
Peter C Elwood, Alex Whitmarsh, John Gallacher, et al.
British Journal of Haematology
|
June 22, 2011
Tyrosine kinase inhibitor insensitivity of non-cycling CD34+ human acute myeloid leukaemia cells with FMS-like tyrosine kinase 3 mutations
Caroline L Alvares, Tino Schenk, Sanna Hulkki, et al.
Haematologica
|
October 26, 2010
Efficacy and outcome of autologous transplantation in rare myelomas
Curly Morris, Mary Drake, Jane Apperley, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
August 16, 2011
Adjusting for patient crossover in clinical trials using external data: a case study of lenalidomide for advanced multiple myeloma
K Jack Ishak, J Jaime Caro, Mark T Drayson, et al.
Haematologica
|
December 10, 2020
Autologous stem cell transplantation is safe and effective for fit older myeloma patients: exploratory results from the Myeloma XI trial
Charlotte Pawlyn, David Cairns, Tom Menzies, et al.
British Journal of Haematology
|
June 12, 2020
Early relapse after high-dose melphalan autologous stem cell transplant predicts inferior survival and is associated with high disease burden and genetically high-risk disease in multiple myeloma
Ceri Bygrave, Charlotte Pawlyn, Faith Davies, et al.
Page
of 23